GlassScriptPhysician profile
Robert T Depond
NPI 1205804374
$29,266.33
in general payments reported to CMS, 2019-2025
24 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,019 · 2020: $1,383 · 2021: $15K · 2022: $7,479 · 2023: $3,139 · 2024: $155 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $437 · Education: $137 · Travel and Lodging: $66.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $436.75 |
| Education | $137.01 |
| Travel and Lodging | $66.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $27,057.17 | 2019-2023 | Gelpoint V-Path |
| Abbvie INC. | $443.38 | 2019-2021 | |
| Ethicon US, LLC | $337.29 | 2019-2025 | Ethicon, Vistaseal, Stratafix |
| Pfizer INC. | $322.00 | 2019-2022 | |
| Gynesonics, INC. | $177.76 | 2023-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medical Device Business Services, INC. | $137.01 | 2025 | Stratafix |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2019 | |
| Mallinckrodt Enterprises LLC | $99.99 | 2019 | |
| Amag Pharmaceuticals, INC. | $92.96 | 2019-2020 | |
| Therapeuticsmd, INC. | $88.09 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $80.81 | 2019-2021 | |
| Astellas Pharma US INC | $75.10 | 2019-2024 | Veozah |
| Sumitomo Pharma America, INC. | $43.81 | 2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $26.41 | 2022 | |
| Convatec INC. | $22.70 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21.94 | 2020 | |
| Sage Therapeutics, LLC | $17.73 | 2024 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Coopersurgical, INC. | $15.90 | 2024 | Wallach Cryosurgical Equipment |
| Acessa Health INC. | $14.37 | 2019 | |
| Avion Pharmaceuticals | $14.02 | 2019 | |
| Allergan, INC. | $13.34 | 2019 | |
| Exeltis, USA INC. | $11.84 | 2022 | |
| Meditrina | $11.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Depond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.